Category Archives: Neuroscience

Neuroscience

The neuroscience of thirst – Tech Explorist

A new study has demonstrated how and which activities outside of the brain contribute to feeling thirsty. The discovery offers a rich neurobiological clarification for a phenomenon that each of us has experienced many times in our lives.

The study identifies previously unknown body-to-brain pathways that work together to govern this fundamental sensation. For this study, Chris Zimmerman (postdoctoral fellow at the Princeton Neuroscience Institute) has received the 2020 Eppendorf & Science Prize for Neurobiology.

The study reveals that signals arise from the mouth and gut, providing predictive information to brain neurons that use these signals to satiate or convey thirst upon eating or drinking.

Zimmerman said,What we have learned about the thirst system should improve our understanding of the brain systems that become dysfunctional in eating disorders, such as obesity and anorexia nervosa, and motivation disorders such as addiction and anhedonia, for example, which could someday lead to new therapies for these diseases.

In the 1950s, Bengt Andersson proposed an answer to the question: where does this sensation come from? He suggested that our brains might contain an osmosensor governs thirst, which consists of a group of cells that sense when dehydrated by directly monitoring the bloods osmolarity.

For the experiments, he systematically infused salt into the brains of goats to locate this osmosensor. He ultimately discovered a small area within the hypothalamus where even minute amounts of salt triggered immediate, voracious drinking. Subsequent studies established that Anderssons osmosensor encompasses the subfornical organ (SFO), a brain region that is distinctively suited to detecting blood osmolarity because it lies outside the blood-brain barrier.

Zimmerman noted a few unresolved gaps in Anderssons study. For one, considering how long it takes for ingested food or water to enter the bloodstream, its a mystery how a gulp of (often cold) water can immediately quench thirst, or how we can crave a drink shortly after a few bites of food. These quick changes in thirst sensations suggest that the sensory cue is regulated on a moment-by-moment basis, operating on a timescale thats quicker than the passage of information through the bloodstream.

Zimmerman said,The traditional model for how these brain structures function, as simple dehydration sensors, was entrenched and written into the textbooks. Demonstrating that thirst neurons also receive predictive sensory information from the rest of the body led us to rewrite these traditional models.

To explore this phenomenon, Zimmerman and his team started by suggesting stimulating and recording calcium movement in mices brains using optical fibers to pinpoint precisely how SFO neurons sense thirst. They affirmed that the thirst neurons could detect a lack of hydration levels by monitoring increases in particle concentration in the blood. In any case, incredibly, the thirst neurons likewise diminished activity when the mouse drank water and increased activity with food intake, suggesting that thirst neurons regulation happened even before chemicals from food and fluids infiltrated the blood.

Zimmerman thus postulated that the second set of signals in addition to input from the bloodstream might feed into the SFO to help the brain dynamically manage a sense of thirst in real-time. Aiming to detect these signals and their origins, he and his team traced the flow of water through the oral and digestive tracts in mice.

They found that as soon as water entered the mouth, the body triggered a near-instantaneous cell signaling pathway that closely tracked the volume of water ingested and inhibited thirst signals from the SFO accordingly.

Zimmerman said,Cold water was particularly effective at inhibiting SFO neurons during this process, which may explain why we find cooler drinks, especially thirst-quenching and pleasurable.

Further mouse experiments where water was directly delivered through an opening on the stomach wall to model the swallowing of fluid revealed a similar body-to-brain signaling pathway in the gut. Once water entered the gut, the body transmitted rapid measurements of real-time particle concentrations in the gut via the brains vagus nerve.

In light of these discoveries and upheld by additional cell imaging examinations, scientists built a potential model for how the body-to-brain signaling pathway coordinates thirst sensation. They suggest that layers of signals emerge from the mouth, gut, and blood and combine in the SFO.

Here, thirst neurons integrate the array of information from various sources to monitor the bodys hydration level, manage the appropriate level of thirst sensation, and provide guidance on whether to continue ingesting water or food. A parallel series of investigations likewise recommended that the body-to-brain regulation of thirst neurons controls downstream signals to change hormone release and emotions.

Zimmerman explained,There may be instances when overwriting the cues related to satisfying thirst is necessary. For one, patients are asked not to consume water before undergoing surgery a common hospital practice. In rare instances, when thirst becomes pathological, patients must overwrite the cue of drinking water to avoid increases in blood pressure and stress in the kidneys. In both cases, doctors prescribe sucking on ice chips and popsicles, or wetting the mouth, triggering the immediate signaling pathway to cope with thirst sensation.

Read more from the original source:
The neuroscience of thirst - Tech Explorist

Neuroscience

Grant to aid in developing new treatments for Alzheimer’s disease – Lethbridge Herald

By Jensen, Randy on October 1, 2020.

LETHBRIDGE HERALD

The University of Lethbridges Majid Mohajerani and two partners from Laval University are creating new tools for neuroscience research that theyll use to test out a promising drug target for Alzheimers disease. If successful, their research could lead to new treatments to prevent the onset of Alzheimers disease symptoms, delay progression of the disease or even restore normal function after symptoms have appeared.

The research is made possible thanks to a grant of nearly $1 million over three years from the Weston Brain Institute, a non-profit institute of the W. Garfield Weston Foundation that supports world-class neuroscience research to accelerate discovery of treatments for neurodegenerative diseases such as Alzheimers and Parkinsons.

New treatments for these diseases are critically needed, says Mohajerani, a professor of neuroscience at the U of Ls Canadian Centre for Behavioural Neuroscience (CCBN), in a news release. Alzheimers disease has an enormous impact on patients, the health-care system and society. This is only anticipated to get worse as the population ages. Current treatments for Alzheimers disease only address some of the symptoms. They do not prevent or alter the course of the disease.

In the project, Mohajerani, along with Laval Universitys Benoit Gosselin and Yves De Koninck, will develop a device that allows for minimally invasive stimulation and recording of brain activity in mice in their home cages. The device includes a wireless transmitter, thus removing the need for the animal to be taken from its home cage and hooked up to wires in the lab. This implant will be combined with an automated monitoring system, currently under development at the CCBN, that records the animals natural behaviour. Together, these devices will allow scientists to measure the brain activity and behaviour of an animal in its home environment over days, weeks or even months.

The technology will enable them to address the idea that abnormal brain activity, characterized by an imbalance between excitatory and inhibitory connections in the brain, underlies the early progression of Alzheimers. De Koninck is a world expert on a certain protein, found on the outer membranes of cells within the nervous system, called potassium chloride co-transporter 2 (KCC2). An increase or decrease in the production of KCC2 affects the balance of inhibitory and excitatory activity in the brain. Pharmaceutical tools that target KCC2 might thus be able to correct the imbalance observed in Alzheimers, as well as other nervous system disorders such as chronic pain.

We are using drugs that modulate the expression of KCC2, says Mohajerani. We will increase and also decrease the production of KCC2 to study both effects. We will explore if activation of KCC2, by boosting neuronal inhibition, can reduce the progression of the disease and if inhibition of KCC2 will increase the progression of the disease.

Using genetically modified mice that model Alzheimers disease pathology and symptoms, the project aims to accelerate the development of therapeutics for Alzheimers by testing how altering KCC2 function affects brain activity and behaviour during disease progression in living animals. If successful, this research would implicate KCC2 as an entirely new drug target for mitigating Alzheimers disease.

See the rest here:
Grant to aid in developing new treatments for Alzheimer's disease - Lethbridge Herald

Neuroscience

Tips to help avoid getting sick as cold and flu season approaches – WTOP

Are you ready for the cold and flu season? Be prepared and make sure you're setting your immune system up for success, a doctor advises.

Are you getting enough vitamin D? It might help keep you from getting sick. Combine the upcoming cold and flu season with the COVID-19 pandemic and its never been more important to have a strong immune system.

Vitamin D is one of the things we really want to make sure we get enough of, especially now, assistant professor of neuroscience Dr. Nicole M. Avena said. Its really one of the critical nutrients that helps to support and boost our immunity.

Avena, who has a doctorate in neuroscience and psychology, teaches at the Mount Sinai School of Medicine and is a visiting professor of health psychology at Princeton University.

A lot of people are deficient in vitamin D and dont even realize it, she said.

And in winter months, people get less vitamin D naturally from the sun. Signs of vitamin D deficiency include lethargy feeling tired.

Also, when you have low vitamin D, it puts you at risk for having issues related to calcium absorption, which puts you more at risk for broken bones, or improper healing of fractures, Avena said.

To help ensure youre getting all the vitamins and micronutrientsyou need to stay healthy, Avena recommends eating a wide variety of different fruits, vegetables and proteins.

If were deficient in one or more micronutrients, then our body has to work harder to make up for that deficiency, Avena said. We have a really effective immune system that can work really, really well if our body doesnt have to be devoting its resources to other aspects of our health.

If you cant get the nutrition you need from food alone and your doctor OKs supplements, there are lots of options to swallowing potentially big pills. There are gummies, liquids and sublingual options that dissolve under your tongue.

Your lifestyle also can influence whether your immune system is strong.

Are you getting enough rest? One bad night isnt such a big problem, but Avena said sleep deficits over time can compromise your immune system.

We need to be getting the appropriate amount of sleep every night so our body can be rested and it can recharge, Avena said.

Also, chill out. When we are stressed and anxious, our body has to work harder to produce cortisol to fight these stressors internally and that leaves fewer resources available to support our immune health, she said.

According to the Centers for Disease Control and Prevention, exercise improves sleep and reduces anxiety.

Like WTOP on Facebook and follow @WTOP on Twitter to engage in conversation about this article and others.

Get breaking news and daily headlines delivered to your email inbox by signing up here.

2020 WTOP. All Rights Reserved. This website is not intended for users located within the European Economic Area.

Originally posted here:
Tips to help avoid getting sick as cold and flu season approaches - WTOP

Neuroscience

The sameness of life in the pandemic could be affecting your neurons – Hindustan Times

Do the days seem without structure, the weeks and months a blur? It could be the effect of the sameness of life in the pandemic, on neurons in the brain.

A paper published in Journal of Neuroscience in September indicates that sameness of stimuli makes certain neurons weary, altering our perception of time.

The paper was co-authored by Masamichi Hayashi at the National Institute of Information and Communications Technology in Suita, Japan, and Richard Ivry at the University of California, Berkeley. Hayashi and Ivry scanned volunteers brains while showing them the same scene a grey spot on a screen 30 times without pause.

After the period of adaptation, participants saw the grey spot again, but for different lengths of time. Then, they estimated how long the object had stayed on screen. Participants could not effectively tell the difference between the durations; at the same time, scans showed decreased activity in a group of brain cells involved in time perception, indicating neuron fatigue, the report states.

Ive always been interested in the neural mechanism of time perception, Hayashi told HT. How is the time experience represented in our brains? Why does time pass so quickly when you are having fun? Why does time slow down when you get into a car accident?

In 2015, Hayashi and Ivry began conducting behavioural experiments to confirm their own earlier brain scan experiment in this area of study. Their volunteers were mainly students aged 18 to 27.

Our experience of time during the pandemic is probably associated with more memory-based recognition of time the perception of time in the passing of days and months which is a different area from the precise focus of our study, Hayashi says. Time estimation in the range of hundreds of milliseconds is important for a variety of daily activities, such as motor control, speech recognition and generation, playing instruments, dancing, etc. We still need to test, but I believe these time-sensitive neurons are involved in these timing-related activities too.

The reports findings may have other real-world applications. Distortions in time perception and timed performances appear in patients with Parkinsons disease, attention deficit hyperactivity disorder, and autism. We hope that our findings will provide some insight to understand these disorders, Hayashi says.

See more here:
The sameness of life in the pandemic could be affecting your neurons - Hindustan Times

Neuroscience

Carolina Union event space reservations to be available starting in November – The Daily Tar Heel

Amisha Garikipati, a junior neuroscience major at UNC, is on the executive board of the Carolina Neuroscience Club. Garikipati said the club has faced difficulties in recruiting new members due to the pandemic.

While the club has been meeting virtually instead of at the Student Union, Garikipati said one positive of going online is that it has presented new opportunities for the club and a chance to attract more people through new platforms.

Even though we do have a fewer turnout now, it has presented some opportunities that wouldn't have been possible before," Garikipati said. "We had someone from the neuroscience club in South Carolina reach out to us and see if we could potentially collaborate."

Garikipati said she is not sure if the club would use the event reservation ability for the spring semester. If members thought it was safe and beneficial, she said the club would do it.

"But I guess we would have to see how things are doing at that point in time and reach out to our members and see if they are comfortable with that and if that's something they'd want to do," she said.

Megan Wagner, a sophomore economics and communications major, serves as secretary for the UNC Young Democrats. She said the club has had a significant decrease in new member recruits due to COVID-19.

"It's just a lot harder to work around getting people to come to meetings in general, especially since everything is virtual and classes have been moved back, so the timing of everything is a lot harder," Wagner said.

Prior to the pandemic, Wagner said UNC Young Democrats reserved a room to hold their weekly cabinet meetings and other events which in the past have included hosting Beto ORourke at the Student Union.

We've used it a lot to host voter registration and lit drops," Wagner said. "Its just a place for everyone to meet, get the materials that we need and disperse off to where you need to go."

Wagner said the club is not yet certain whether it will use the Union in the spring semester. But some precautions she would personally like to see are temperature screenings, hand sanitizer stations, masks required and 6 feet of social distancing.

It really depends on so many different things if we're on campus, if COVID is not as rampant as it is currently and we are able to safely have officer meetings, then probably," Wagner said. "But if it's not safe, then well probably just stick to virtual."

university@dailytarheel.com

Continued here:
Carolina Union event space reservations to be available starting in November - The Daily Tar Heel

Neuroscience

Cogstate Expands Executive Team with Key Scientific Appointments – GlobeNewswire

Melbourne, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Neuroscience technology company, Cogstate Ltd (ASX.CGS), announced today the appointment of Chris Edgar, PhD as Chief Science Officer and Prof. Paul Maruff, PhD as Chief Innovation Officer. These appointments represent an expansion of the executive leadership team with strengthened scientific capacity as the company continues to meet the growing demand for transformative innovations in clinical trials and healthcare.

As Chief Science Officer, Dr. Edgar will continue to advise Cogstate customers on clinical endpoint strategy and will set the strategic vision for Cogstates global scientific services. He will lead a team of clinical experts focused on the optimization, execution and analyses of cognitive and behavioral assessments and related data quality assurance solutions for improved signal detection and excellence in trial design and conduct.

Moving into the newly created role of Chief Innovation Officer, Prof. Maruff will lead efforts to continue to refine existing Cogstate technologies as well as identifying and developing novel methods for assessment of cognition and behaviour. He will continue to oversee Cogstate relationships supporting innovation and development with partners from pharmaceutical and biotechnology companies and with key industry and academic groups central to the scientific advancements of Cogstate technologies.

Adding scientific strength to the Cogstate leadership team will further position us for this current phase of growth as we continue to see increasing demand for strong, stable delivery supported by rapid, robust innovation, said Brad OConnor, Cogstate CEO. Among the current opportunities for the company are awards in late phase global clinical trial programs, the increased need for remote data collection and smart-phone based assessment, as well as rapidly evolving needs in healthcare for early detection of cognitive impairment. Dr. Edgars experience in pharmaceutical and contract research organizations brings an enormous depth to our drug development expertise and measurement science excellence in clinical trials. With his expertise, Paul can re-double his efforts to bring forward new strategies for measuring disease-related and treatment-related changes in cognition, remaining at the center of innovation at Cogstate.

About Chris Edgar

Dr. Chris Edgar is an experienced leader in cognitive assessment and clinical endpoint strategy who provides expert guidance to Cogstates pharmaceutical customers throughout all stages of trial conduct, from study design and test selection through final analysis. Dr. Edgar is also a key advisor to Cogstates commercial and product teams for the application of new technologies and approaches aligned with industry needs. Prior to joining Cogstate as Senior Vice President, Clinical Science in 2018, Dr. Edgar oversaw clinical endpoint strategy for multiple neuroscience indications in the Patient-Centered Outcomes Research group at Roche. He holds a PhD in psychopharmacology from Northumbria University and has nearly two decades of pharmaceutical industry experience. Dr. Edgar has held other key industry positions including Clinical Scientist at Roche on Schizophrenia and Alzheimers disease drug development programs, Senior Clinical Lead for rater training and data quality at Bracket, and Scientific Director at Cognitive Drug Research Ltd., a computerized cognitive assessment company.

About Paul Maruff

Professor Paul Maruff is one of the founders of Cogstate and served as Chief Science Officer before taking on the role of Chief Innovation Officer. He is a neuropsychologist with expertise in the identification and measurement of subtle behavioral and cognitive dysfunction. Prof. Maruffs research integrates conventional and computerized neuropsychological testing with cognitive neuroscientific methods to guide decision making in drug development and in clinical medicine. He has worked extensively on methods to identify subtle neurocognitive impairmentand to assess the efficacy of pharmacological treatmentin Alzheimers disease, mild cognitive impairment and the HIV dementia complex. He has extended this approach to identify cognitive dysfunction and monitor treatment efficacy in psychiatric diseases such as schizophrenia, obsessive-compulsive disorder and depression in adults, attention deficit disorder, developmental dyspraxia and substance abuse in children. Paul remains an active researcher; he is appointed Professor at the Florey Institute for Neuroscience and Mental Health, and he is currently clinical co-chair of the Australian Imaging Biomarkers and Lifestyle (AIBL) study. Paul has published over 450 research articles in international peer-reviewed scientific journals and has co-authored 15 book chapters.

About Cogstate

Cogstate Ltd (ASX:CGS) is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Cogstate technologies provide rapid, reliable and highly sensitive computerized cognitive tests across a growing list of domains and support electronic clinical outcome assessment (eCOA) solutions to replace costly and error-prone paper assessments with real-time data capture. The companys clinical trials solutions include quality assurance services for study endpoints that combine innovative operational approaches, advanced analytics and scientific consulting. For 20 years, Cogstate has proudly supported the leading-edge research needs of biopharmaceutical companies and academic institutions and the clinical care needs of physicians and patients around the world. In the Healthcare market, in August 2019 Cogstate entered into an exclusive licensing agreement with pharmaceutical company Eisai, under which Eisai will market Cogstate technologies as digital cognitive assessment tools in Japanese markets. The product, branded as NouKNOW, launched in Japan on 31 March 2020 (nouknow.jp). To learn more, visit:http://www.cogstate.com/.

Read this article:
Cogstate Expands Executive Team with Key Scientific Appointments - GlobeNewswire

Neuroscience

Okinawa Institute of Science and Technology Graduate University Deploys AMD EPYC Processors with Over 2 Petaflops of Computing Power Dedicated to…

AMD EPYC Processors provide superior cost-performance and high core density

TOKYO, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Today, AMD (NASDAQ: AMD) and Okinawa Institute of Science and Technology Graduate University (OIST) , announced the deployment of AMD EPYC 7702 processors for use in a new, high performance computing system. The EPYC processor-based supercomputer will deliver the 2.36 petaflops of computing power OIST plans to use for scientific research at the University.

The Scientific Computing & Data Analysis Section (SCDA) of OIST plans to implement the new supercomputer for supporting OIST computationally intensive research ranging from bioinformatics, computational neuroscience, and physics. SCDA adopted AMD EPYC after significant growth, including a 2X increase in users.

2020 is a milestone year for OIST with new research units expanding the number of research areas. This growth is driving a significant increase in our computational needs, said Eddy Taillefer, Ph.D., Section Leader, Scientific Computing & Data Analysis Section. Under the common resource model for which the computing system is shared by all OIST users we needed a significant increase in core-count capacity to both absorb these demands and cope with the significant growth of OIST. The latest AMD EPYC processor was the only technology that could match this core-count need in a cost-performance effective way.

Key factors of OISTs selection of the AMD EPYC processors included superior cost-performance, memory/PCIe bandwidth, and high core counts per server. OIST plans to also consider EPYC processors for other growing computational needs for University researchers in the future.

AMD is proud to be working with leading global institutions to bring scientific research to the forefront through the power of high performance computing technology, said Ram Peddibhotla, corporate vice president, EPYC product management, AMD. With high performance capabilities, ease of management and scalability, 2nd Gen AMD EPYC processors can assist OIST researchers with advancing technological innovations and supporting their research goals in bioinformatics, computational neuroscience, and physics.

AMD EPYC 7702 Processor Specifications

Supporting Resources

About AMDFor 50 years AMD has driven innovation in high-performance computing, graphics, and visualization technologies the building blocks for gaming, immersive platforms, and the datacenter. Hundreds of millions of consumers, leading Fortune 500 businesses and cutting-edge scientific research facilities around the world rely on AMD technology daily to improve how they live, work and play. AMD employees around the world are focused on building great products that push the boundaries of what is possible. For more information about how AMD is enabling today and inspiring tomorrow, visit the AMD (NASDAQ: AMD) website, blog, Facebook and Twitter pages.

1 Max boost for AMD EPYC processors is the maximum frequency achievable by any single core on the processor under normal operating conditions for server systems. EPYC-18

AMD, the AMD Arrow logo, EPYC, and combinations thereof, are trademarks of Advanced Micro Devices, Inc. Other names are for informational purposes only and may be trademarks of their respective owners.

Contact:Gary SilcottAMD Communications(512) 602-0889gary.silcott@amd.com

Laura GravesAMD Investor Relations(408) 749-5467laura.graves@amd.com

Read the original here:
Okinawa Institute of Science and Technology Graduate University Deploys AMD EPYC Processors with Over 2 Petaflops of Computing Power Dedicated to...

Neuroscience

AMD EPYC Processors Deployed with Over 2 Petaflops of Computing Power – I-Connect007

AMD and Okinawa Institute of Science and Technology Graduate University (OIST) , announced the deployment of AMD EPYC 7702 processors for use in a new, high performance computing system. The EPYC processor-based supercomputer will deliver the 2.36 petaflops of computing power OIST plans to use for scientific research at the University.

The Scientific Computing & Data Analysis Section (SCDA) of OIST plans to implement the new supercomputer for supporting OIST computationally intensive research ranging from bioinformatics, computational neuroscience, and physics. SCDA adopted AMD EPYC after significant growth, including a 2X increase in users.

2020 is a milestone year for OIST with new research units expanding the number of research areas. This growth is driving a significant increase in our computational needs, said Eddy Taillefer, Ph.D., Section Leader, Scientific Computing & Data Analysis Section. Under the common resource model for which the computing system is shared by all OIST users we needed a significant increase in core-count capacity to both absorb these demands and cope with the significant growth of OIST. The latest AMD EPYC processor was the only technology that could match this core-count need in a cost-performance effective way.

Key factors of OISTs selection of the AMD EPYC processors included superior cost-performance, memory/PCIe bandwidth, and high core counts per server. OIST plans to also consider EPYC processors for other growing computational needs for University researchers in the future.

AMD is proud to be working with leading global institutions to bring scientific research to the forefront through the power of high performance computing technology, said Ram Peddibhotla, corporate vice president, EPYC product management, AMD. With high performance capabilities, ease of management and scalability, 2ndGen AMD EPYC processors can assist OIST researchers with advancing technological innovations and supporting their research goals in bioinformatics, computational neuroscience, and physics.

Excerpt from:
AMD EPYC Processors Deployed with Over 2 Petaflops of Computing Power - I-Connect007

Neuroscience

Former Ghoraghat UNO Wahida Khanam, who was critically injured in an attack, comes out of the National Institute of Neuroscience and Hospital (NINH)…

Vendor Information

Editor: A.M. MUFAZZAL, Managing Editor: ARSHAD HOSEIN. Printed and published by MAINUL HOSEIN from the New Nation Printing Press. The New Nation, 1 R.K. Mission Road,Ittefaq Bhaban (3rdfloor), Dhaka-1203, Bangladesh,Phones: PABX: 47115875, 47115879, 47114514,Fax : 880-2-47115865, Email: For News: n_editor@bangla.net, n_news@bangla.net,For Advertisement nnation@bangla.net

View post:
Former Ghoraghat UNO Wahida Khanam, who was critically injured in an attack, comes out of the National Institute of Neuroscience and Hospital (NINH)...

Neuroscience

Neuroscience Market Size, Key Trends, Challenges and Standardization, Research, Key Players, Economic Impact and Forecast to 2026(Siemens…

Los Angeles, United State, QY Research recently added a research report, Global Neuroscience Market Research Report 2020 to its ever-increasing repository. The research report discusses the future of the global Neuroscience market. It highlights the drivers and restraints and sheds light on the undercurrents defining the threats and opportunities. The research report is projected to provide the readers with a thorough evaluation of factors influencing the global Neuroscience market. To serve the same purpose, analysts have used a SWOT analysis and Porters five forces analysis. These evaluations are supported by unbiased opinions of market experts.

The assessment of the global Neuroscience market is determined with mention of global figures and CAGR for the forecast period. Analysts have also included the historic figures for the mentioned segments and the forecast ones to help the readers understand the progress each part of the global Neuroscience market will make in the coming years.

Get PDF template of this report:

https://www.qyresearch.com/index/detail/1437954/global-neuroscience-market

Global Neuroscience Market: Drivers and Restraints

The thorough evaluation of the global Neuroscience market includes a complete explanation of the drivers present in the market. Analysts have studied the investments in research and development, the impact of changing economies, and consumer behaviors to ascertain the factors that will drive the overall market. In addition, analysts have also tried to factor in changes in manufacturing activities and industrial operations that will determine the sales of the products in the global Neuroscience market.

This chapter also explains the possible restraints present in the global Neuroscience market. It assesses the reasons that could hamper the growth of the market. Analysts have evaluated the rising environmental concerns and fluctuating cost of raw materials that is projected to dampen the spirit of the global Neuroscience market. However, analysts have also presented potential opportunities that the players in the global Neuroscience market can bank on. The chapter on drivers, restraints, threats, and opportunities presents a holistic view of the global Neuroscience market.

Key players cited in the report:

GE Healthcare, Siemens Healthineers, Noldus Information Technology, Mightex Bioscience, Thomas RECORDING GmbH, Blackrock Microsystems, Tucker-Davis Technologies, Plexon, Phoenix Technology Group, NeuroNexus, Alpha Omega Neuroscience

Global Neuroscience Market: Competitive Landscape

Analysts have thoroughly assessed the competitive landscape present in the global Neuroscience market. The report includes the study of the key players operating in the Neuroscience market. It also details the strategic initiatives that the companies have taken in recent years to keep up with the intensifying competition. In addition, it also includes an evaluation of the financial outlook of these companies, their research and development plans, and their business strategies going forward.

Global Neuroscience Market: Segment Analysis

This chapter focuses on the various segments present in the global Neuroscience market. The report segments the market based on type, application, product, service, and end users. This breakdown allows a granular view of the subject. It helps in understanding the changes in production and overall needs of consumers that are likely to influence these segments.

Global Neuroscience Market by Type Segments:

, Whole Brain Imaging, Neuro-Microscopy, Electrophysiology Technologies, Neuro-Cellular Manipulation, Stereotaxic Surgeries, Animal Behavior, Other, Whole Brain Imaging, Neuro-Microscopy, and Electrophysiology Technologies are the top three types of neuroscience, with a combined market share of 62% Neuroscience

Global Neuroscience Market by Application Segments:

, Hospitals, Diagnostic Laboratories, Research Institutes, Other, Neuroscience is applied mostly in the hospital with a market share of 47%. It is followed by Research Institutes and Diagnostic Laboratories

Global Neuroscience Market: Regional Analysis

The chapter on regional analysis highlights the political scenario in emerging economies and developed nations that are expected to influence the demand and supply dynamics. The regional analysis also helps in ascertaining the shifting needs of the population that have a critical impact on the overall Neuroscience market. Cost of labor, raw materials, and production costs depending on the region have also been factored in this part of the research report.

Enquire Customization In the Report:

https://www.qyresearch.com/customize-request/form/1437954/global-neuroscience-market

Key Questions Answered

The report answers important questions that companies may have when operating in the global Neuroscience market. Some of the questions are given below:

Answering such types of questions can be very helpful for players to clear their doubts when implementing their strategies to gain growth in the global Neuroscience market. The report offers a transparent picture of the real situation of the global Neuroscience market so that companies can operate more effectively. It can be customized according to the needs of readers for better understanding of the global Neuroscience market.

Table of Content

1 Report Overview1.1 Study Scope1.2 Key Market Segments1.3 Players Covered: Ranking by Neuroscience Revenue1.4 Market Analysis by Type1.4.1 Global Neuroscience Market Size Growth Rate by Type: 2020 VS 20261.4.2 Whole Brain Imaging1.4.3 Neuro-Microscopy1.4.4 Electrophysiology Technologies1.4.5 Neuro-Cellular Manipulation1.4.6 Stereotaxic Surgeries1.4.7 Animal Behavior1.4.8 Other1.5 Market by Application1.5.1 Global Neuroscience Market Share by Application: 2020 VS 20261.5.2 Hospitals1.5.3 Diagnostic Laboratories1.5.4 Research Institutes1.5.5 Other1.6 Coronavirus Disease 2019 (Covid-19): Neuroscience Industry Impact1.6.1 How the Covid-19 is Affecting the Neuroscience Industry

1.6.1.1 Neuroscience Business Impact Assessment Covid-19

1.6.1.2 Supply Chain Challenges

1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products1.6.2 Market Trends and Neuroscience Potential Opportunities in the COVID-19 Landscape1.6.3 Measures / Proposal against Covid-19

1.6.3.1 Government Measures to Combat Covid-19 Impact

1.6.3.2 Proposal for Neuroscience Players to Combat Covid-19 Impact1.7 Study Objectives1.8 Years Considered 2 Global Growth Trends by Regions2.1 Neuroscience Market Perspective (2015-2026)2.2 Neuroscience Growth Trends by Regions2.2.1 Neuroscience Market Size by Regions: 2015 VS 2020 VS 20262.2.2 Neuroscience Historic Market Share by Regions (2015-2020)2.2.3 Neuroscience Forecasted Market Size by Regions (2021-2026)2.3 Industry Trends and Growth Strategy2.3.1 Market Top Trends2.3.2 Market Drivers2.3.3 Market Challenges2.3.4 Porters Five Forces Analysis2.3.5 Neuroscience Market Growth Strategy2.3.6 Primary Interviews with Key Neuroscience Players (Opinion Leaders) 3 Competition Landscape by Key Players3.1 Global Top Neuroscience Players by Market Size3.1.1 Global Top Neuroscience Players by Revenue (2015-2020)3.1.2 Global Neuroscience Revenue Market Share by Players (2015-2020)3.1.3 Global Neuroscience Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.2 Global Neuroscience Market Concentration Ratio3.2.1 Global Neuroscience Market Concentration Ratio (CR5 and HHI)3.2.2 Global Top 10 and Top 5 Companies by Neuroscience Revenue in 20193.3 Neuroscience Key Players Head office and Area Served3.4 Key Players Neuroscience Product Solution and Service3.5 Date of Enter into Neuroscience Market3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026)4.1 Global Neuroscience Historic Market Size by Type (2015-2020)4.2 Global Neuroscience Forecasted Market Size by Type (2021-2026) 5 Neuroscience Breakdown Data by Application (2015-2026)5.1 Global Neuroscience Market Size by Application (2015-2020)5.2 Global Neuroscience Forecasted Market Size by Application (2021-2026) 6 North America6.1 North America Neuroscience Market Size (2015-2020)6.2 Neuroscience Key Players in North America (2019-2020)6.3 North America Neuroscience Market Size by Type (2015-2020)6.4 North America Neuroscience Market Size by Application (2015-2020) 7 Europe7.1 Europe Neuroscience Market Size (2015-2020)7.2 Neuroscience Key Players in Europe (2019-2020)7.3 Europe Neuroscience Market Size by Type (2015-2020)7.4 Europe Neuroscience Market Size by Application (2015-2020) (2015-2020) (2015-2020) (2015-2020) (2015-2020) 8 Key Players Profiles8.1 GE Healthcare8.1.1 GE Healthcare Company Details8.1.2 GE Healthcare Business Overview and Its Total Revenue8.1.3 GE Healthcare Neuroscience Introduction8.1.4 GE Healthcare Revenue in Neuroscience Business (2015-2020))8.1.5 GE Healthcare Recent Development8.2 Siemens Healthineers8.2.1 Siemens Healthineers Company Details8.2.2 Siemens Healthineers Business Overview and Its Total Revenue8.2.3 Siemens Healthineers Neuroscience Introduction8.2.4 Siemens Healthineers Revenue in Neuroscience Business (2015-2020)8.2.5 Siemens Healthineers Recent Development8.3 Noldus Information Technology8.3.1 Noldus Information Technology Company Details8.3.2 Noldus Information Technology Business Overview and Its Total Revenue8.3.3 Noldus Information Technology Neuroscience Introduction8.3.4 Noldus Information Technology Revenue in Neuroscience Business (2015-2020)8.3.5 Noldus Information Technology Recent Development8.4 Mightex Bioscience8.4.1 Mightex Bioscience Company Details8.4.2 Mightex Bioscience Business Overview and Its Total Revenue8.4.3 Mightex Bioscience Neuroscience Introduction8.4.4 Mightex Bioscience Revenue in Neuroscience Business (2015-2020)8.4.5 Mightex Bioscience Recent Development8.5 Thomas RECORDING GmbH8.5.1 Thomas RECORDING GmbH Company Details8.5.2 Thomas RECORDING GmbH Business Overview and Its Total Revenue8.5.3 Thomas RECORDING GmbH Neuroscience Introduction8.5.4 Thomas RECORDING GmbH Revenue in Neuroscience Business (2015-2020)8.5.5 Thomas RECORDING GmbH Recent Development8.6 Blackrock Microsystems8.6.1 Blackrock Microsystems Company Details8.6.2 Blackrock Microsystems Business Overview and Its Total Revenue8.6.3 Blackrock Microsystems Neuroscience Introduction8.6.4 Blackrock Microsystems Revenue in Neuroscience Business (2015-2020)8.6.5 Blackrock Microsystems Recent Development8.7 Tucker-Davis Technologies8.7.1 Tucker-Davis Technologies Company Details8.7.2 Tucker-Davis Technologies Business Overview and Its Total Revenue8.7.3 Tucker-Davis Technologies Neuroscience Introduction8.7.4 Tucker-Davis Technologies Revenue in Neuroscience Business (2015-2020)8.7.5 Tucker-Davis Technologies Recent Development8.8 Plexon8.8.1 Plexon Company Details8.8.2 Plexon Business Overview and Its Total Revenue8.8.3 Plexon Neuroscience Introduction8.8.4 Plexon Revenue in Neuroscience Business (2015-2020)8.8.5 Plexon Recent Development8.9 Phoenix Technology Group8.9.1 Phoenix Technology Group Company Details8.9.2 Phoenix Technology Group Business Overview and Its Total Revenue8.9.3 Phoenix Technology Group Neuroscience Introduction8.9.4 Phoenix Technology Group Revenue in Neuroscience Business (2015-2020)8.9.5 Phoenix Technology Group Recent Development8.10 NeuroNexus8.10.1 NeuroNexus Company Details8.10.2 NeuroNexus Business Overview and Its Total Revenue8.10.3 NeuroNexus Neuroscience Introduction8.10.4 NeuroNexus Revenue in Neuroscience Business (2015-2020)8.10.5 NeuroNexus Recent Development8.11 Alpha Omega10.11.1 Alpha Omega Company Details10.11.2 Alpha Omega Business Overview and Its Total Revenue10.11.3 Alpha Omega Neuroscience Introduction10.11.4 Alpha Omega Revenue in Neuroscience Business (2015-2020)10.11.5 Alpha Omega Recent Development 9 Analysts Viewpoints/Conclusions 10 Appendix10.1 Research Methodology10.1.1 Methodology/Research Approach10.1.2 Data Source10.2 Disclaimer10.3 Author Details

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.

Read more:
Neuroscience Market Size, Key Trends, Challenges and Standardization, Research, Key Players, Economic Impact and Forecast to 2026(Siemens...